Buy the dip NOW on one ASX lithium stock with 6.5% yield, and these healthcare shares

Experts reckon heavy discounting makes these investments no-brainer buys.

| More on:
A man scoots in superman pose across a bride, excited about a future with electric vehicles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sometimes excellent companies present eye-opening buy-the-dip opportunities.

That's because share prices are a reflection of market sentiment — which includes fear and greed — not necessarily business performance.

Humans act irrationally, including stock investors.

So here is a pair of ASX shares shunned by the market in recent weeks that experts are tipping as golden buying opportunities right now:

The lithium miner that will 'deliver'

If you ever wanted to get a piece of the lithium action, this could be your chance.

That's because global prices for the mineral are down this year due to weak Chinese demand, and consequently weakening the valuations of lithium miners. However, many analysts reckon in the long run, the world will only want more of the good stuff for a low-carbon future.

One of the bigger producers, Pilbara Minerals Ltd (ASX: PLS), has seen its stock price plunge more than 28% since 10 August.

Medallion Financial Group director Philippe Bui reckons Pilbara will end up an outstanding investment once lithium prices normalise.

"Pilbara is trading on an undemanding price/earnings ratio," Bui told The Bull.

"The company aims to produce a million tonnes by the end of 2025, a significant increase on existing production."

Pilbara Minerals also has plenty of money in the bank while paying a fully franked 6.5% dividend yield.

"The company paid a fully franked full-year dividend of 25 cents a share in fiscal year 2023," said Bui.

"The lithium company had $3.3 billion of cash on its balance sheet when announcing its full-year results… Provided lithium prices settle in what has been a recent downturn, Pilbara should be able to deliver."

Time to buy the dip on a much-discussed ASX stock

Resmed CDI (ASX: RMD) is a contender for most-discussed ASX stock over the past few weeks, as the healthcare share has lost one-third of its value since early August.

Red Leaf Securities chief John Athanasiou noted that the rise of new drugs like Ozempic is striking fear into investors.

"ResMed makes medical devices to treat sleep-disordered breathing.

"RedMed has been oversold on investor concerns that diabetes and obesity medicines will impact future sales of the company's sleep apnoea products."

However, both he and Bui reckon investors with long horizons need not worry.

"We believe these concerns are overblown," said Athanasiou.

"The cheaper share price provides an opportunity to invest in a blue chip company that offers long-term growth prospects."

Bui admitted one metric was weak in the August financial report, but the temptation to buy the dip is too great now.

"Margins were slightly softer than expected in the company's last quarterly results. From a long-term perspective, we see the recent pullback as an attractive entry point."

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

Image from either construction, mining or the oil industry of a friendly worker.
Cheap Shares

Buy these 2 impressive ASX shares in June: experts

Experts are fans of these businesses. Here’s why.

Read more »

Broker working with share prices on computers.
Cheap Shares

Why UBS thinks Magellan shares could deliver a 15% return in the next year

The broker is excited about this stock.

Read more »

Happy work colleagues give each other a fist pump.
Cheap Shares

Morgans names 2 cheap ASX 200 shares to buy

The leading broker thinks these shares are being undervalued by the market.

Read more »

Happy couple looking at a phone and waiting for their flight at an airport.
Cheap Shares

2 ASX 300 shares to buy this month: experts

These stocks could be leading opportunities according to one expert.

Read more »

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
Cheap Shares

Is this beaten-up stock the best value buy in the ASX 200?

An expert has outlined why this stock is an attractive opportunity.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Cheap Shares

2 compelling ASX shares on sale right now

These businesses look like low-priced opportunities.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Cheap Shares

2 ASX shares that I rate as cheap buys after the market rally

I still rate these stocks as bargain buys after shares recovered from April’s sell-off.

Read more »

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Cheap Shares

Is it time to buy these 2 beaten-up ASX shares in 2025?

I’m bullish about these two ASX shares that have gone through a sell-off.

Read more »